Company · Healthtech & Bio

Evolving Therapeutics

evolvingtherapeutics.es ↗ ·Valencia ·Pre-seed

Evolving Therapeutics is a biotech spin-off of the Universitat de València that develops bacteriophage-based solutions for the prevention, diagnosis and treatment of multidrug-resistant bacteria, under a One Health approach spanning human, animal and plant health. Founded in 2023 by sisters Marisa and Pilar Domingo-Calap, it operates from the Parc Científic of the Universitat de València in Paterna (Valencia) and claims the first commercial personalised phage-therapy service in Spain. It closed a €100K round from Angels (Juan Roig's investment vehicle) in January 2025, was accelerated by Lanzadera, and won the 2026 EmprendeXXI award for the Valencian Community.

Founded

2023

Founders

News

Rounds

Investors

SectorsBiotech, Phage therapy, Antimicrobial resistance, Healthtech, Agtech, Animal health Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Profile updated 30 Aug 2026

Founders

Marisa Domingo-Calap

Co-founder & CEO

Pilar Domingo-Calap

Co-founder & Chief Scientific Officer

Global models

No comparables on record yet.

Investors 3

Universitat de València

www.uv.es ↗

Investor Spain

Funding rounds 1

Pre-seed · €100K

Angels, Juan Roig's investment vehicle, invested €100,000 in Evolving Therapeutics, a University of Valencia spin-off using bacteriophages a…

2025-01-21

News & media 7

Published	Article
2026-04-16	Evolving Therapeutics gana los Premios EmprendeXXI en la Comunidad Valenciana como la startup con mayor potencial ↗ El Independiente
2026-01-12	Evolving Therapeutics, awarded at the Expansión Start Up Awards ↗ PCUV News (Science Park, University of Valencia)
2025-06-18	ARTHEx Biotech, Evolving Therapeutics and Optical Sens, awarded at the Santander X 2025 awards in the Startup category ↗ PCUV News (Science Park, University of Valencia)
2025-01-21	Evolving Therapeutics spin-off receives private funding from Angels to tackle multidrug-resistant bacteria with phages ↗ Universitat de València
2024-11-29	Pioneering research by the University and the CSIC uses bacteria viruses against Xylella fastidiosa in the Balearic Islands ↗ I2SysBio (CSIC–Universitat de València)
2024-03-21	Evolving Therapeutics, la startup que combate bacterias multirresistentes con virus que se las comen ↗ Innovaspain
2023-05-19	EVOLVING THERAPEUTICS, new biotech spin-off of the University of Valencia located at I2SysBio ↗ PCUV News (Science Park, University of Valencia)